Capital International Investors Sarepta Therapeutics, Inc. Call Options Transaction History
Capital International Investors
- $475 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SRPT
# of Institutions
559Shares Held
85.8MCall Options Held
3.67MPut Options Held
1.75M-
Black Rock Inc. New York, NY10.3MShares$1.35 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.04MShares$1.18 Billion0.03% of portfolio
-
State Street Corp Boston, MA4.14MShares$540 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X03.82MShares$497 Million0.33% of portfolio
-
Avoro Capital Advisors LLC New York, NY3MShares$391 Million6.47% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $11.4B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...